Undecylenic Acid
Best-in-class: Formula SF722
A long-standing fatty-acid formula traditionally used to support healthy gut flora balance and manage yeast/candida overgrowth. The filed panel is one active and nothing else: 250 mg of 10-undecenoic acid across five gelcaps, suspended in olive oil.
Undecylenic Acid quick facts
| Suggested dose | As directed, often a several-week course. |
| How often | A several-week course, not continuous |
| Who it's for | Gut-flora balance and yeast-management protocols. |
The better-persisting of the antifungal fatty acids, and the hyphal-transition mechanism is a more sophisticated target than membrane disruption alone. It is also an established topical antifungal for skin. Same honest caveat as caprylic acid: intestinal candidiasis is diagnosed far more often than it is demonstrated.
How Undecylenic Acid actually works
An unsaturated fatty acid with antifungal activity, inhibiting the morphological switch from yeast to the invasive hyphal form of Candida — which is arguably more useful than simply killing yeast, since the hyphal form is what penetrates tissue. It has better mucosal persistence than caprylic acid because it is absorbed more slowly.
Where to get Undecylenic Acid
Buy Formula SF722 at Thorne →What it is, why it recurs, and where this fits — free to read.
The evidence for Undecylenic Acid
Graded by what exists behind each claim.
✅ Clinically validated
- Undecylenic acid has antifungal activity (established mechanistically; used topically for fungal infections).
- Oral gut-yeast use is largely traditional/clinical-practice with limited formal trials.
📊 Correlative data
- Candida overgrowth tracks with antibiotic use, high sugar intake and gut symptoms.
🧪 Theoretical / extrapolated benefits
- The 'candida' framework is popular in functional medicine; internal-overgrowth diagnosis is debated.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Undecylenic Acid actually does
The molecule is 10-undecenoic acid: an 11-carbon fatty acid with a terminal double bond, made industrially by cracking ricinoleic acid from castor oil. It is not an azole, not a polyene and not an echinocandin. It does not target ergosterol synthesis, it does not punch holes in the membrane at achievable concentrations, and it does not target the cell wall. What it does is stranger and more interesting.
It blocks a shape change. Candida albicans switches between a budding yeast form and an invasive filamentous form, and the filamentous form is the one that penetrates epithelium. Undecylenic acid was identified as the compound leaching out of dental resilient liners that inhibits that switch: of 10 liners tested, 2 inhibited the yeast-to-hypha transition and a third stimulated it, and the inhibitor was undecylenic acid McLain 2000. That is a morphogenesis inhibitor rather than a fungicide, and the distinction governs everything the product can honestly claim.
The wider family says the same thing. Related medium-chain fatty acids — capric and caprylic acid — suppress Candida albicans virulence factors through several targets at once rather than through one enzyme Jadhav 2017. Fatty acids of this length sit close, structurally, to the quorum-sensing signal the organism uses to hold itself in the yeast form, which is a plausible reason a simple lipid can talk to a developmental program.
Now the part that decides whether the oral product can work, and it is on no label. Undecylenic acid is a weak carboxylic acid with a pKa near 4.9. Only the undissociated, protonated form is lipophilic enough to cross a fungal membrane. At the pH of skin, around 5.5, a meaningful fraction is protonated. In the jejunum and ileum, at pH 6 to 7.5, more than 95% of it exists as the undecylenate anion, and an anion does not cross a membrane. The same molecule is a different drug at 2 pH units higher.
And it is absorbed like the fat it is. An 11-carbon fatty acid in an oil-filled softgel is handled by the small intestine as dietary lipid, not as a luminal antiseptic. Whatever fraction is taken up in the proximal gut never reaches the colon, so the delivered dose at the site the marketing describes is unknown and is certainly a fraction of what was swallowed. No pharmacokinetic study has ever measured it.
Cell, rodent, human — and where it stops
In cells, and that is where the mechanism lives. The morphogenesis result is a laboratory observation on cultured C. albicans McLain 2000, and the multi-target work on the related fatty acids is likewise in vitro Jadhav 2017. Both are real results and neither involves a gut.
In animals: nothing that bears on the oral use. There is no rodent model of gastrointestinal Candida overgrowth treated with oral undecylenic acid that would sit between the culture dish and the capsule. That step is simply missing from the chain.
In people, on skin. The human evidence is dermatological and it is 46 years old: undecylenic acid with zinc undecylenate, as a powder, in culture-positive tinea pedis Chretien 1980. This is why the compound has a regulatory identity at all — it is a recognized topical antifungal, applied to the organism, at skin pH.
In people, by mouth: no randomized trial exists. For any gastrointestinal endpoint, at any dose, against placebo. The product has been sold continuously for decades and there is no controlled human trial of it. Stating that is not a rhetorical device; it is the translation step, and it is empty.
The obstacle is the route, and it changes 3 things at once. The evidence is topical, at the site, at pH 5.5, against a dermatophyte on keratin Chretien 1980. The product is oral, absorbed, at pH 7, aimed at a commensal yeast in a mucus-lined lumen. Not one of those conditions carries over.
The second obstacle is the diagnosis itself. Fungal overgrowth of the small intestine is a real described entity — and it is defined by culturing an aspirate taken at endoscopy, not by a symptom questionnaire, a stool yeast report or a sugar-craving list Erdogan 2015. Most people taking this have not had that test, which means the target of treatment has not been shown to be present.
Undecylenic Acid — which form, and does it matter
The dose is knowable, and here it is. The classic formula delivers 50 mg of 10-undecenoic acid per gelcap and 250 mg per 5-gelcap serving, in an olive oil base in a bovine gelatin shell, and the label directs 5 gelcaps 2 to 3 times daily. That is 500 to 750 mg of undecylenic acid a day, and 10 to 15 softgels. Any reader deciding whether this is worth doing should have those numbers in front of them, because they are the only quantitative facts the product offers.
Free acid against zinc salt: these are the 2 different products. The topical evidence used undecylenic acid together with zinc undecylenate as a powder Chretien 1980. The oral product is the free acid dissolved in oil. Different solubility, different pH behavior, different site. The salt is not an oral version of the acid and the acid is not an oral version of the topical result.
Nothing about this product targets the colon. No enteric coat, no delayed release, no colonic delivery system. It is a fatty acid in oil released in the stomach, which is the design most likely to have it absorbed before it reaches anywhere the label talks about.
Two label details that matter to real people and are never mentioned. The shell is bovine gelatin, which excludes a number of readers outright. And 15 softgels a day is a meaningful load of olive oil, which is its own reason for the loose stools people attribute to die-off.
What would have to be true, and how you would know it was not
1. The prediction that cuts hardest against the product. Predict a stool fungal culture or quantitative Candida count is essentially unchanged after a 4-week course. There is no published human pharmacokinetic study showing that any inhibitory concentration reaches the colon, and the pH argument above says most of the compound arrives ionized even if it arrives. Retest at 4 weeks with the same lab and the same method.
2. If it does work, the mechanism dictates a specific and unusual shape. A morphogenesis inhibitor disarms rather than kills McLain 2000. So predict symptoms improve WITHOUT the yeast count falling. That is a strange prediction and it is the honest one, and it means any marketing that promises to clear or eradicate yeast is promising something this mechanism does not do.
3. Timescale, and the confound that will be blamed for everything. Predict any effect appears in the first 7 to 14 days and does not deepen after. Predict too that sugar and alcohol went out of the diet in the same week, because they almost always do, and that confound is larger than anything a fatty acid is likely to contribute.
4. Nothing systemic should move. Predict cbc shows no eosinophilia and hs-crp is unchanged at 12 weeks. If a person has systemic symptoms that resolve on 750 mg of a dietary fatty acid, the most likely explanation is that the diagnosis was never fungal.
5. The test that should come first. If the target is small intestinal fungal overgrowth, that is established by aspirate culture Erdogan 2015. Predict that most people who take a several-week course have never had one, and that the ones who have are the only group in whom any of this is answerable.
What nobody has tested yet
There is no oral pharmacokinetic study, and it is the study that decides everything. Give 250 mg, draw plasma over 8 hours, measure undecylenic acid and its metabolites, and measure it in stool. That single experiment would say whether the oral product can reach the colon at all. It has never been published, and without it every claim for the oral form is an assumption about absorption.
Nobody has tested the pH prediction. Repeat the morphogenesis assay McLain 2000 at pH 5.5, 6.5 and 7.4 and read off how much activity survives ionization. It is one plate and 3 buffers, and it would either rescue the oral rationale or end it.
Nobody has run a randomized trial of the oral product. Not once, in decades of continuous sale. Four weeks, against placebo, in people with aspirate-confirmed fungal overgrowth Erdogan 2015, with symptom scores and repeat culture. That is a small study and it is the only one anybody needs.
And nobody has compared it with the fatty acids it is usually sold beside. Caprylic acid products make an overlapping claim and have their own in vitro file Jadhav 2017. A head-to-head has never been attempted, so the choice between them is made entirely on packaging.
Undecylenic Acid — its own safety story, not its category's
The compound itself is unusually benign, and that is the least interesting thing about its safety. It is a dietary-type fatty acid; the reported oral problem is gastrointestinal upset, and topical use irritates skin. No established significant drug interactions. On a toxicity scale this sits near the bottom of the shelf.
The real risk on this page is diagnostic, and it is specific. A several-week antifungal course started on the strength of a symptom list is several weeks not spent finding out what the symptoms are. Fungal overgrowth is diagnosed by aspirate culture Erdogan 2015; bloating, fatigue and sugar craving are compatible with celiac disease, bacterial overgrowth, giardia, inflammatory bowel disease, an eating pattern and a thyroid. Weight loss, blood, iron deficiency, nocturnal symptoms or a family history of bowel cancer should route to a clinician before they route to a capsule.
The die-off framing is the mechanism by which that delay is sold back to you. Feeling worse in week 1 is interpreted as evidence the product is working, which converts an adverse effect into a confirmation. On a product delivering 10 to 15 oil-filled softgels a day, the more parsimonious explanation for new gastrointestinal upset is 10 to 15 oil-filled softgels a day.
The exclusions nobody prints. The shell is bovine gelatin. The active is derived from castor oil. Neither is a toxicity concern and both are absolute exclusions for some readers, and neither appears in the marketing.
Pregnancy and breastfeeding are unstudied, which here means exactly what it says. Not that harm was found; that these are the populations excluded from trials, and for this product there are no oral trials to have been excluded from.
Sources read for this page
- McLain N, Ascanio R, Baker C, Strohaver RA, Dolan JW. Undecylenic acid inhibits morphogenesis of Candida albicans. Antimicrobial Agents and Chemotherapy 2000 · PMID 10991877
- Chretien JH, Esswein JG, Sharpe LM, Kiely JJ, Lyddon FE. Efficacy of undecylenic acid-zinc undecylenate powder in culture positive tinea pedis. International Journal of Dermatology 1980 · PMID 6987185
- Jadhav A, Mortale S, Halbandge S, et al. The Dietary Food Components Capric Acid and Caprylic Acid Inhibit Virulence Factors in Candida albicans Through Multitargeting. Journal of Medicinal Food 2017 · PMID 28922057
- Erdogan A, Rao SS. Small intestinal fungal overgrowth. Current Gastroenterology Reports 2015 · PMID 25786900
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: The specific symptoms you attributed to yeast before you started, written down first — because that list tends to grow to fit the treatment. Recurrent oral or vaginal thrush is visible and countable; candida as a whole-body explanation is not, and a several-week course is only interpretable against symptoms you named in advance.
- How long before it means anything: Four to six weeks, the length these courses usually run, with the end date set before you start. Open-ended antifungal courses are how people end up nine months into a protocol with no way to say whether any of it did anything.
- What will fool you: The diet that arrives with the protocol. Candida programs run alongside sugar and alcohol restriction, and that alone shifts bloating, thrush frequency and how you feel at 4pm. Genuine recurrent thrush also has a common medical cause worth excluding first — an HbA1c is a cheaper answer than a course of anything.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Undecylenic Acid — safety & side effects
- GI upset orally; skin irritation topically.
- Generally well tolerated. No established significant drug interactions.
- Long-term safety has not been characterized — the trials run weeks to months, not years. That is a real limit on what anyone can tell you about daily use for a decade. Not established as safe in pregnancy or breastfeeding — not because harm is documented, but because these are the two populations systematically excluded from the trials. Absence of data is not reassurance.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Undecylenic Acid in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Undecylenic Acid
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | Anemia is the commonest sign of a gut absorbing badly |
| Ferritin | Iron is the first thing malabsorption takes |
| Vitamin B12 | The second thing, and the one with permanent consequences |
| hs-CRP (High-Sensitivity C-Reactive Protein) | Separates inflammatory bowel disease from IBS |
The Gut Health & Absorption panel covers these in one order — 11 markers, $208.80 with the discount applied.
Check results you already have → · All 103 markers A–Z
Undecylenic Acid — frequently asked questions
What is Undecylenic Acid?
A long-standing fatty-acid formula traditionally used to support healthy gut flora balance and manage yeast/candida overgrowth. The filed panel is one active and nothing else: 250 mg of 10-undecenoic acid across five gelcaps, suspended in olive oil.
What is the suggested dose of Undecylenic Acid?
As directed, often a several-week course. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Undecylenic Acid dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Undecylenic Acid?
Coach Cam sources Undecylenic Acid from Thorne, with 10% off auto-applied at checkout — use the buy link on this page.
What Undecylenic Acid is used for
Undecylenic Acid appears under 1 goal in the goal router.
Related Gut & Digestion supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.